Unmet needs of biochemical biomarkers for human prion diseases
Although the development of aggregation assays has noticeably improved the accuracy of the clinical diagnosis of prion diseases, research on biomarkers remains vital. The major challenges to overcome are non-invasive sampling and the exploration of new biomarkers that may predict the onset or reflec...
Saved in:
Main Authors: | Peter Hermann, Inga Zerr |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Prion |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19336896.2024.2349017 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer’s and Parkinson’s disease
by: Bing Xu, et al.
Published: (2025-02-01) -
Novel method for classification of prion diseases by detecting PrPres signal patterns from formalin-fixed paraffin-embedded samples
by: Sachiko Koyama, et al.
Published: (2024-12-01) -
Exploring CJD incidence trends: insights from Slovakia
by: Pavol Skacik, et al.
Published: (2024-12-01) -
Multidimensional features of sporadic Creutzfeldt-Jakob disease in the elderly: a case report and systematic review
by: Jiangfeng Liao, et al.
Published: (2024-04-01) -
Corrigendum: Multidimensional features of sporadic Creutzfeldt-Jakob disease in the elderly: a case report and systematic review
by: Jiangfeng Liao, et al.
Published: (2025-02-01)